Irreversible enzyme inhibitors. CXIV. Proteolytic enzymes. IV. Additional active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from phenoxyacetamides bearing a terminal sulfonyl fluoride.
作者信息
Baker B R, Hurlbut J A
出版信息
J Med Chem. 1968 Mar;11(2):241-5. doi: 10.1021/jm00308a010.
PMID:5654209
Abstract
摘要
相似文献
1
Irreversible enzyme inhibitors. CXIV. Proteolytic enzymes. IV. Additional active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from phenoxyacetamides bearing a terminal sulfonyl fluoride.
J Med Chem. 1968 Mar;11(2):241-5. doi: 10.1021/jm00308a010.
2
Irreversible enzyme inhibitors. 113. Proteolytic enzymes. 3. Active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from phenoxyacetamides with an N-fluorosulfonylphenyl substituent.
J Med Chem. 1968 Mar;11(2):233-41. doi: 10.1021/jm00308a009.
3
Irreversible enzyme inhibitors. CXLV. Proteolytic enzymes. 8. Active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from alpha-(2-carboxy-4-chlorophenoxy)acetamide bearing a terminal sulfonyl fluoride.
J Med Chem. 1969 Jan;12(1):118-22. doi: 10.1021/jm00301a030.
4
Irreversible enzyme inhibitors. CXV. Proteolytic enzymes. V. Active-site-directed irreversible inhibitors of trypsin derived from p-(phenoxyalkoxy) benzamidines with a terminal sulfonyl fluoride.不可逆酶抑制剂。CXV. 蛋白水解酶。V. 源自对（苯氧基烷氧基）苯甲脒并带有末端磺酰氟的胰蛋白酶活性位点导向不可逆抑制剂。
J Med Chem. 1968 Mar;11(2):245-9. doi: 10.1021/jm00308a011.
5
6
Irreversible enzyme inhibitors. CXLIV. Proteolytic enzymes. VII. Additonal active-site-directed irreversible inhibitors of trypsin derived from m- and p-(phenoxyalkoxy)benzamidines with a terminal sulfonyl fluoride.
J Med Chem. 1969 Jan;12(1):112-7. doi: 10.1021/jm00301a029.
7
Irreversible enzyme inhibitors. 138. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 6-(p-aminomethylphenethyl)-- 2,4-diamino-5-(3,4-dichlorophenyl)pyrimidine with a terminal sulfonyl fluoride.
J Med Chem. 1969 Jan;12(1):89-91. doi: 10.1021/jm00301a023.
8
Irreversible enzyme inhibitors. CXXV. Active-site-directed irreversible inhibitors of xanthine oxidase derived from arylpurines and pyrazolo[3,4-d]pyrimidines bearing a terminal sulfonyl fluoride.
J Med Chem. 1968 Jul;11(4):656-61. doi: 10.1021/jm00310a005.
9
Irreversible enzyme inibitiors. CLXXII. Proteolytic enzymes. XVI. Covalent bonding of the sulfonyl fluoride group to serine outside the active site of alpha-chymotrypsin by exo-type active-site directed irreversible inhibitors.
J Med Chem. 1970 May;13(3):467-70. doi: 10.1021/jm00297a030.
10
Irreversible enzyme inhibitors. CXLII. Further studies on active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-Aminophenoxypropyl)-2,4,6-triaminopyrimidine bearing a terminal sulfonyl fluoride.
J Med Chem. 1969 Jan;12(1):104-7. doi: 10.1021/jm00301a027.
引用本文的文献
1
Sulfur fluoride exchange.硫氟交换
Nat Rev Methods Primers. 2023;3. Epub 2023 Aug 3.
2
Diversity Oriented Clicking (DOC): Divergent Synthesis of SuFExable Pharmacophores from 2-Substituted-Alkynyl-1-Sulfonyl Fluoride (SASF) Hubs.导向多样性点击反应（DOC）：从 2-取代-炔基-1-磺酰氟（SASF）连接子出发发散合成 SuFEx 反应基团。
Angew Chem Int Ed Engl. 2020 Jul 20;59(30):12460-12469. doi: 10.1002/anie.202003219. Epub 2020 Jun 4.
3
SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase.SuFEx 使能的人中性粒细胞弹性蛋白酶共价抑制剂的无偏倚发现。
Proc Natl Acad Sci U S A. 2019 Sep 17;116(38):18808-18814. doi: 10.1073/pnas.1909972116. Epub 2019 Sep 4.
4
Arylfluorosulfate-Based Electrophiles for Covalent Protein Labeling: A New Addition to the Arsenal.基于芳基氟硫酸酯的亲电试剂用于共价蛋白质标记：一种新的武器加入。
Angew Chem Int Ed Engl. 2019 Jan 21;58(4):957-966. doi: 10.1002/anie.201806037. Epub 2018 Oct 26.
5
Arylfluorosulfates Inactivate Intracellular Lipid Binding Protein(s) through Chemoselective SuFEx Reaction with a Binding Site Tyr Residue.芳基氟硫酸酯通过与结合部位 Tyr 残基的化学选择性 SuFEx 反应使细胞内脂质结合蛋白失活。
J Am Chem Soc. 2016 Jun 15;138(23):7353-64. doi: 10.1021/jacs.6b02960. Epub 2016 Jun 2.
Zotero 插件